Process Development & Manufacturing: Capabilities and Best Practices

Victor Beaumont, PhD,
Strategic Market Development Specialist at Bruker UK Limited

Leveraging NMR Spectroscopy for High-resolution Structure Characterization of TIDES

Click to play video

Nuclear magnetic resonance (NMR) spectroscopy is considered the “gold-standard” for structure characterization of small molecules and proteins because of its inherent sensitivity to structural changes, atomic resolution, and quantitative nature. A resurgence of research in peptides and oligonucleotides (TIDES) has brought NMR at the forefront of analytical techniques for characterizing these modalities. Recent advancements in NMR technology accelerate the development and characterization of novel therapeutic TIDES and generic products.

Victor has studied and applied NMR techniques throughout his undergraduate studies at the University at Buffalo (Dr. Thomas Szyperski) and PhD program at Yale University (Dr. Patrick Loria). He later joined Pfizer as an NMR specialist for biotherapeutic structure characterization moving then to project management of analytical laboratory automation. His passion is in improving the quality of life and working efficiencies of society by facilitating and contributing high-quality scientific innovation focused on state-of-the-art NMR characterization of novel therapeutic modalities. At Bruker, he is dedicated to working with scientists in understanding the challenges and needs of the industry to expand NMR applications and technology.